Stock Performance and Price Movement
On 24 Nov 2025, Tarsons Products touched an intraday low of Rs.198.7, representing its lowest price point in the past year and an all-time low for the company. The stock recorded a day’s decline of 4.25%, underperforming its sector by 4.95%. This marks the sixteenth consecutive trading day of losses, during which the stock has delivered a cumulative return of -28.35%. Intraday volatility was notable at 5.92%, calculated from the weighted average price, indicating significant price fluctuations throughout the session.
Further technical indicators show that Tarsons Products is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a persistent downward momentum in the stock’s price over multiple time horizons.
Comparative Market Context
In contrast to Tarsons Products’ performance, the broader market has exhibited resilience. The Sensex opened 88.12 points higher and was trading at 85,343.57, a 0.13% gain on the day. The index remains close to its 52-week high of 85,801.70, just 0.54% away, and has recorded a 2.56% gain over the past three weeks. Mega-cap stocks have been leading this upward trend, with the Sensex trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a bullish market environment.
Over the last year, Tarsons Products has delivered a return of -46.48%, significantly lagging behind the Sensex’s 7.85% gain. The stock’s 52-week high was Rs.465, underscoring the extent of the decline to its current levels.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Financial Metrics and Profitability Trends
Tarsons Products’ financial results have reflected challenges over recent periods. The company’s quarterly profit after tax (PAT) stood at Rs.3.32 crores, showing a decline of 51.8% compared to the average of the previous four quarters. This contraction in profitability has contributed to the stock’s subdued performance.
The return on capital employed (ROCE) for the half-year period was recorded at 6.69%, the lowest level observed, indicating reduced efficiency in generating returns from capital investments. The debt-to-equity ratio for the same period was 0.41 times, the highest recorded, signalling a relatively increased leverage position.
Despite these figures, the company maintains a strong ability to service its debt, with an average EBIT to interest coverage ratio of 12.03, suggesting that interest obligations remain comfortably manageable.
Institutional Investment and Market Participation
Institutional investors have reduced their stake in Tarsons Products by 3.27% over the previous quarter, collectively holding 5.91% of the company’s shares. This reduction in institutional participation may reflect a shift in market assessment of the company’s fundamentals relative to other investment opportunities.
Over the past three years, the stock has consistently underperformed the BSE500 benchmark, with annual returns falling short each year. The one-year return of -46.39% further emphasises the stock’s relative underperformance within the broader market context.
Valuation and Peer Comparison
Tarsons Products currently exhibits a return on capital employed of approximately 3.9 and an enterprise value to capital employed ratio of 1.5, suggesting a fair valuation relative to its capital base. The stock is trading at a discount compared to the average historical valuations of its peers within the healthcare services sector.
Profitability has declined by around 30% over the past year, aligning with the stock’s negative return profile. These factors contribute to the current market pricing and reflect the company’s recent financial trajectory.
Tarsons Products or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Recent Trends
Tarsons Products’ stock has experienced a prolonged period of decline, culminating in a fresh 52-week low of Rs.198.7. The stock’s performance has been marked by sustained negative returns, elevated volatility, and trading below all major moving averages. Financial indicators reveal contraction in profitability and increased leverage, while institutional investors have reduced their holdings.
In contrast, the broader market and sector indices have shown resilience, with the Sensex approaching its own 52-week high and maintaining a positive trajectory over recent weeks. This divergence highlights the specific challenges faced by Tarsons Products within the healthcare services sector.
While the company’s ability to service debt remains strong, the combination of declining profits, subdued returns on capital, and reduced institutional participation has contributed to the current valuation and price levels.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
